Jane Street’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Jane Street’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-137,133	Closed	-$17.8K	–	10028
2023 Q1	$17.8K	Sell	137,133 -55,371	-29%	-$11.3K	﹤0.01%	8668
2022 Q4	$31.6K	Buy	+192,504	New	+$80.6K	﹤0.01%	8490
2022 Q1	–	Sell	-46,737	Closed	-$374K	–	11340
2021 Q4	$374K	Sell	46,737 -138,479	-75%	-$1.62M	﹤0.01%	7774
2021 Q3	$3.58M	Buy	185,216 +171,586	+1,259%	+$3M	﹤0.01%	3332
2021 Q2	$188K	Buy	+13,630	New	+$161K	﹤0.01%	8880

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Jane Street's PLXP Position: Q2 2023 in Review

Jane Street sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 137,133 shares — an estimated $17.8K sold.

Jane Street first reported a position in PLXP in Q2 2021 and held it in 5 quarters. The position peaked at $3.58M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Jane Street reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Jane Street sold 137,133 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $17.8K.
Jane Street first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Jane Street's PLx Pharma Inc. Common Stock position peaked at $3.58M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.